Colgate-Palmolive (NYSE:CL) Price Target Raised to $90.00

Colgate-Palmolive (NYSE:CLFree Report) had its target price hoisted by Deutsche Bank Aktiengesellschaft from $83.00 to $90.00 in a research report sent to investors on Monday morning,Benzinga reports. They currently have a hold rating on the stock.

Several other brokerages have also recently commented on CL. Raymond James Financial reduced their target price on Colgate-Palmolive from $105.00 to $95.00 and set an “outperform” rating on the stock in a report on Monday, October 20th. Evercore ISI dropped their price target on shares of Colgate-Palmolive from $100.00 to $94.00 and set an “outperform” rating on the stock in a research report on Monday, November 3rd. Jefferies Financial Group set a $85.00 price objective on shares of Colgate-Palmolive in a research note on Tuesday, December 16th. Royal Bank Of Canada upgraded shares of Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 price objective for the company in a research report on Tuesday, December 9th. Finally, Barclays set a $83.00 target price on shares of Colgate-Palmolive in a report on Friday, January 16th. Eleven investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $94.47.

Get Our Latest Stock Report on Colgate-Palmolive

Colgate-Palmolive Price Performance

CL stock opened at $94.29 on Monday. The company has a market capitalization of $76.00 billion, a P/E ratio of 35.99, a PEG ratio of 4.22 and a beta of 0.29. The company has a fifty day moving average price of $81.56 and a 200-day moving average price of $81.50. The company has a debt-to-equity ratio of 5.90, a quick ratio of 0.27 and a current ratio of 0.42. Colgate-Palmolive has a 52-week low of $74.54 and a 52-week high of $100.18.

Colgate-Palmolive (NYSE:CLGet Free Report) last posted its quarterly earnings data on Friday, January 30th. The company reported $0.95 earnings per share for the quarter, beating analysts’ consensus estimates of $0.91 by $0.04. The business had revenue of $5.23 billion during the quarter, compared to the consensus estimate of $5.13 billion. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.Colgate-Palmolive’s quarterly revenue was up 5.8% on a year-over-year basis. During the same period in the prior year, the business posted $0.91 earnings per share. As a group, equities analysts expect that Colgate-Palmolive will post 3.75 EPS for the current year.

Colgate-Palmolive Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Wednesday, January 21st will be issued a dividend of $0.52 per share. The ex-dividend date is Wednesday, January 21st. This represents a $2.08 annualized dividend and a dividend yield of 2.2%. Colgate-Palmolive’s payout ratio is currently 79.39%.

Institutional Trading of Colgate-Palmolive

A number of hedge funds and other institutional investors have recently bought and sold shares of CL. Westside Investment Management Inc. grew its stake in Colgate-Palmolive by 85.5% in the 2nd quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock valued at $26,000 after purchasing an additional 130 shares during the period. Maseco LLP bought a new stake in shares of Colgate-Palmolive during the 4th quarter worth $27,000. Copia Wealth Management purchased a new position in shares of Colgate-Palmolive in the 3rd quarter worth about $29,000. Vermillion & White Wealth Management Group LLC grew its position in Colgate-Palmolive by 86.1% during the second quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company’s stock valued at $30,000 after buying an additional 155 shares during the period. Finally, Cloud Capital Management LLC purchased a new stake in Colgate-Palmolive during the third quarter worth about $30,000. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Company Profile

(Get Free Report)

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.

Featured Stories

Analyst Recommendations for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.